$FLEX

Advaithi Revathi sold $342K of FLEX

Advaithi Revathi (Chief Executive Officer) sold 2,644 shares of FLEX LTD. (FLEX) at $129.18 ($0.34M total) on 2026-05-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Advaithi Revathi
Published May 27, 2026, 12:21 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 27, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FLEX
Neutral
medium confidence
Mentioned
$FLEX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FLEXNeutralLow
01

Why it matters

Because the sale is explicitly under a Rule 10b5-1 plan, it is generally treated as less informative about near-term company prospects; trading impact is therefore expected to be muted unless paired with other catalysts not mentioned here.

02

Market read

A disclosed insider sale at a known price level with 10b5-1 framing—typically low incremental information for valuation.

03

What to watch

The article provides no context on total insider holdings changes over time, whether sales are part of a scheduled cadence, or any concurrent corporate news.

Relevance 6/10Timing: Immediate disclosure (filed 2026-05-26) but transaction occurred 2026-05-22.

Background

The article is an SEC Form 4 insider transaction disclosure for FLEX, reporting an officer/director sale under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$FLEXNeutralMedium confidence
Context

FLEX CEO Advaithi Revathi sold 2,644 shares in an open-market transaction for ~$341.6K under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any move would be more about broader tape/earnings expectations than this single Form 4.

Evidence & confidence

The filing is a routine SEC Form 4 with a stated 10b5-1 plan, which typically lowers interpretive value for near-term price direction.

Market effects

No clear sector read-across from a single officer sale under 10b5-1.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with valuation/positioning changes and may modestly pressure sentiment if investors view it as risk-off.

Key entities

  • FLEX

    Company whose CEO executed an open-market sale of shares disclosed on Form 4.

  • Advaithi Revathi

    FLEX CEO/director who sold 2,644 shares for ~$341.6K under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FLEXHighAI 9/10

Why is Flex stock surging today?

Flex (FLEX) stock rose 8.6% pre-market after Q2 2027 earnings beat estimates, with EPS at $1.18 vs. $1.06 and revenue at $8.5B vs. $8.17B. Management raised FY2027 guidance, and BofA reiterated a Buy rating. The stock had previously fallen below its 52-week high of $166.86.

$FLEXMedAI 9/10

Flex earnings beat by $0.12, revenue topped estimates

Flex reported Q2 EPS of $1.18, beating estimates by $0.12, with revenue at $8.5B, exceeding expectations. The company forecasted FY 2027 EPS of $4.84-$5.16 and revenue of $34.90B-$35.90B. Shares are down 26.73% over 3 months but up 26.10% year-over-year, with a 'fair performance' financial health score.

$FLEXHighAI 9/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

FLEX LTD. (FLEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. P R E S S R E L E A S E EXHIBIT 99.1 FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS • Reported Q2 net sales of $8.5 billion, up 25% versus the prior year. • Delivered Q2 GAAP operating margin of 4.9%, and adjusted operating margin of 7.1%. • Reported Q2 GAAP EPS of $0.70, and re

$FLEXMedAI 8/10

FLEX REPORTS SECOND QUARTER FISCAL 2027 RESULTS

Flex reported Q2 2027 net sales of $8.5B, up 25% YoY. GAAP EPS was $0.70, adjusted EPS $1.18. CEO Revathi Advaithi highlighted growth and a planned spin-off. Q3 guidance: sales $8.87B-$9.17B, adjusted EPS $1.19-$1.25. FY2027 guidance updated to sales $34.9B-$35.9B, adjusted EPS $4.84-$5.16.